BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, February 22, 2026
Home » Topics » Financings, Medical technology

Financings, Medical technology
Financings, Medical technology RSS Feed RSS

Financings for Oct. 27, 2020

Oct. 27, 2020
Med-tech firms raising money in public or private financings, including: Abm Respiratory Care, Caris Life Sciences, Eucrates Biomedical, Helius Medical Technologies, Intuitive Surgical.
Read More

Financings for Oct. 26, 2020

Oct. 26, 2020
Med-tech firms raising money in public or private financings, including: Goodcell, Lux Health Tech.
Read More
Device image

EU takes stake in Carthera to boost development of ultrasound-based technology for treating brain cancer

Oct. 26, 2020
By Bernard Banga
PARIS – Carthera SAS, of Paris, has obtained a $2.4 million grant and $12.5 million equity investment from the European Innovation Council (EIC) for the development of its ultrasound-based medical device for treating glioblastoma.
Read More

Financings for Oct. 23, 2020

Oct. 23, 2020
Med-tech firms raising money in public or private financings, including: Eucrates Biomedical Acquisition, Vapotherm, Xtant Medical Holdings.
Read More
10-22-Lenire-Device-hero

Neuromod scoops up €10.5M in series B funding

Oct. 22, 2020
By Meg Bryant
Neuromod Devices Ltd., which is developing an at-home, self-managed treatment for tinnitus, closed a €10.5 million (US$12.4 million) series B financing led by majority investor Fountain Healthcare Partners. The funds are earmarked for expanding European commercialization of the Lenire tinnitus treatment device, to scale up manufacturing, progress U.S. FDA regulatory approval and pursue opportunities with the U.S. Department of Veterans Affairs (VA).
Read More

Financings for Oct. 22, 2020

Oct. 22, 2020
Med-tech firms raising money in public or private financings, including: Cricket Health, Enviral Tech, Helius Medical Technologies, Invivo Therapeutics Holdings, Neodynamics.
Read More

Financings for Oct. 21, 2020

Oct. 21, 2020
Med-tech firms raising money in public or private financings, including: Astrotech, Eargo, Loyal, Phreesia.
Read More

Financings for Oct. 20, 2020

Oct. 20, 2020
Med-tech firms raising money in public or private financings, including: Cloudmd Software & Services, Diality, Medlite ID, Neuromod Devices, Stagezero Life Sciences.
Read More
Product image rendering

Butterfly Medical takes flight with $7M series B financing and positive feasibility data

Oct. 20, 2020
By Annette Boyle
Butterfly Medical Ltd. could be on the verge of metamorphosis into a major player in the benign prostatic hyperplasia treatment field. The Yokneam, Israel-based company just raised $7 million in a series B financing led by New Rhein Healthcare Investors LLC, of Philadelphia.
Read More

Financings for Oct. 16, 2020

Oct. 16, 2020
Med-tech firms raising money in public or private financings, including: Eargo, Mdxhealth, Nephros.
Read More
Previous 1 2 … 204 205 206 207 208 209 210 211 212 … 254 255 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing